Company: NMP
Filing Date: 2025-06-05
Form Type: S-1/A
Source: 0001213900-25-051324
Chunk: 199

Company: NMP Acquisition Corp.
Filing Date: 2025-06-05
Form: S-1/A
Chunk 199
---
ular Student Alliance, a non -profitorganization that educates high school and college students regarding secularism and scientific reasoning. She has previously served on the board of Sequoyah School, a non -profitprivate school serving the ages from K -8. Ms. Priya is well qualified to serve on our board of directors because of her substantial financial and operations experience. Adam Bensonwill become our independent director upon the commencement of trading of our units on Nasdaq. He has served as Chief Technology Officer at VMG Strategic Consulting Inc., a consulting firm specializing in technology infrastructure and strategic business counsel, since August 2024. Prior to VMG Strategic Consulting, Inc., from June 2023 until August 2024, Mr.Benson served as the Founder at Tagd Consulting, where he provided consulting services related to mergers and acquisitions, capital raising and other general advisory services. Mr.Benson also served as Chief Technology Officer at CXApp Inc. from April 2023 until June 2023, and, before joining CXApp Inc., he served as Chief Technology Officer at Inpixon from September 2018 until April 2023. Mr.Benson holds a Master of Business Administration in Business and Data Analytics from the Louisiana State University Shreveport, and a Bachelor of Business Administration in Business from the Memorial University of Newfoundland. Mr.Benson is well qualified to serve on our board of directors because of his significant experience in accounting and finance, as well as information security, cybersecurity and artificial intelligence. Dr. Vanila M. Singhwill become our independent director upon the commencement of trading of our units on Nasdaq. She has served as a Clinical Associate Professor at the Stanford University School of Medicine for over 20 years, focusing on pain management, regional anesthesia and advance ultrasound -guidedprocedures. She also served as the Chief Medical Officer for the U.S. Department of Health and Human Services from June 2017 to July 2019, and as Acting Regional Health Administrator for Region9, which is comprised of certain U.S. states and territories, where she chaired an inter -agencytask force federally required by Comprehensive Addiction and Recovery Act of 2016, authored a report to the U.S. Congress and managed national public and subcommittee meetings and others. Further, Dr. Singh has served in board of directors of certain public companies — including BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a specialty pharmaceutical company that focused on pain management and addiction medicine, from November 2019 until its acquisition in March 202